Dogwood Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.48K Sell
18
-11
-38% -$6.17K ﹤0.01% 394
2026
Q1
$16.3K Buy
29
+14
+93% +$8.98K 0.01% 272
2025
Q4
$10.1K Buy
15
+5
+50% +$3.4K ﹤0.01% 290
2025
Q3
$6.39K Hold
10
﹤0.01% 350
2025
Q2
$5.39K Buy
10
+6
+150% +$2.87K ﹤0.01% 419
2025
Q1
$1.68K Sell
4
-1,486
-100% -$645K ﹤0.01% 372
2024
Q4
$616K Buy
1,490
+215
+17% +$94.3K 0.33% 59
2024
Q3
$644K Buy
1,275
+188
+17% +$91.3K 0.37% 46
2024
Q2
$530K Buy
1,087
+394
+57% +$198K 0.33% 51
2024
Q1
$374K Buy
+693
New +$379K 0.25% 55
2023
Q4
Hold
0
337

Other funds holding IDXX

Dogwood Wealth Management's IDXX Position: Q2 2026 in Review

Dogwood Wealth Management reduced its Idexx Laboratories (IDXX) stake by 38% in Q2 2026, selling an estimated $6.17K and leaving 18 shares worth $9.48K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

Dogwood Wealth Management first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $644K in Q3 2024. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Dogwood Wealth Management held 18 shares of Idexx Laboratories worth $9.48K as of Q2 2026.
  • Dogwood Wealth Management sold 11 Idexx Laboratories shares in Q2 2026, an estimated $6.17K.
  • Idexx Laboratories made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #394 holding.
  • Dogwood Wealth Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • Dogwood Wealth Management's Idexx Laboratories position peaked at $644K in Q3 2024.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.